Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: Report of two cases [5]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 4, 2006, Pages 566-567

  Della Marca, Giacomo ^a   Vollono, C ^a   Mariotti, P ^a   Mazza, M ^a   Mennuni, G F ^a   Tonali, P ^a   Mazza, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; FERRITIN; GABAPENTIN; IRON; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

ADULT; CASE REPORT; CLINICAL FEATURE; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; IRON THERAPY; LETTER; LIMB MOVEMENT; MALE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP; SLEEP PATTERN; SYMPTOM;

ADULT; ANTICONVULSANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NOCTURNAL MYOCLONUS SYNDROME; PIRACETAM; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 33645562210     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.075671     Document Type: Letter

References (5)

1. Schapira AHV. Restless legs syndrome. An update on treatment options. Drugs 2004;64:149-58.
2. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19.
3. Lynch BA, Lambeng N, Nocka K, et al. The synoptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 2004;101:9861-6.
4. Enggaard TP, Klitgaard NA, Sindrup SH. Specific effect of levetiracetam in experimental human pain models. Eur J Pain, 2005 June 6; [Epub ahead of print].
5. Zesiewicz TA, Sullivan KL, Maldonado JL, et al. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease. Mov Disord 2005;20:1205-9.